Literature DB >> 1326883

Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique.

G D Dodd1, W J Miller, R L Baron, M L Skolnick, W L Campbell.   

Abstract

OBJECTIVE: Patients with hepatic cirrhosis are at an increased risk of developing primary malignant tumors of the liver. If these tumors are discovered early, current therapies may be curative. We conducted a prospective study to assess the accuracy of sonographic screening for the detection of malignant tumors in cirrhotic livers as determined by correlation with resected whole livers. SUBJECTS AND METHODS: A total of 200 prospectively interpreted preoperative sonograms from 200 patients with cirrhosis who underwent hepatic transplantation were correlated with specimens of freshly resected whole livers. The results were analyzed to determine the sensitivity and specificity of sonography in identifying patients with malignant tumors and detecting individual tumors in each patient.
RESULTS: Pathologic examination showed 80 malignant lesions in 34 patients (28 with hepatocellular carcinoma, three with cholangiocarcinoma, two with metastases, and one with non-Hodgkin's lymphoma) and three hemangiomas in two patients. Sonography correctly showed malignant tumors in 17 of the 34 patients, for a sensitivity of 50%. Sonograms were false-positive for malignant tumors in three patients, two of whom had a total of three hemangiomas. Sonography correctly showed 36 of the 80 malignant lesions, for a lesion sensitivity of 45% and specificity of 98%. Of the 44 missed lesions, 24 were 1 cm or less, 12 were between 1 and 3 cm, and eight were more than 3 cm in diameter.
CONCLUSION: Our results show that sonography is highly insensitive in the detection of malignant lesions in end-stage cirrhotic livers and thus is not a reliable screening technique. However, because of sonography's very high specificity, any sonographically identified lesion in a cirrhotic liver should be considered malignant until proved otherwise.

Entities:  

Mesh:

Year:  1992        PMID: 1326883     DOI: 10.2214/ajr.159.4.1326883

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.

Authors:  C S Peña; S Saini; R L Baron; B A Hamm; G Morana; R Caudana; A Giovagnoni; A Villa; A Carriero; D Mathieu; M W Bourne; M A Kirchin; G Pirovano; A Spinazzi
Journal:  Korean J Radiol       Date:  2001 Oct-Dec       Impact factor: 3.500

3.  A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes.

Authors:  Jean C Emond; Benjamin Samstein; John F Renz
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

Review 4.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

5.  Liver transplantation for hepatocellular carcinoma.

Authors:  J McPeake; R Williams
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

6.  Poor sensitivity of sonography in detection of hepatocellular carcinoma in advanced liver cirrhosis: accuracy of pretransplantation sonography in 118 patients.

Authors:  Wei Chiang Liu; Jae Hoon Lim; Cheol Keun Park; Min Ju Kim; Seung Hoon Kim; Soon Jin Lee; Won Jae Lee; Hyo Keun Lim
Journal:  Eur Radiol       Date:  2003-02-05       Impact factor: 5.315

Review 7.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

8.  Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Karin L Andersson; Joshua A Salomon; Sue J Goldie; Raymond T Chung
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

9.  [Ultrasound during follow-up of carcinoma].

Authors:  G Arlt; E Fuhrmann
Journal:  Chirurg       Date:  2007-05       Impact factor: 0.955

10.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.